<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="nervous system [2]. Hereditary ataxia is characterised by pyramidal syndrome," exact="movement disorder," post="seizure, peripheral neuropathy and cognitive dysfunction [3]. Furthermore, HA"/>
 <result pre="Hereditary ataxia is characterised by pyramidal syndrome, movement disorder, seizure," exact="peripheral neuropathy" post="and cognitive dysfunction [3]. Furthermore, HA patients often present"/>
 <result pre="ataxia is characterised by pyramidal syndrome, movement disorder, seizure, peripheral" exact="neuropathy" post="and cognitive dysfunction [3]. Furthermore, HA patients often present"/>
 <result pre="X-linked ataxia [3]. Among the autosomal dominant cerebellar ataxias (ADCA)," exact="spinocerebellar ataxia" post="(SCA) 3 is the most common subtype, followed by"/>
 <result pre="of polyglutamine-coding Cytosine-Adenine-Guanine (CAG) repeats [6]. Another ACDA subtype is" exact="episodic ataxia" post="(EA), which include the common EA1 and 2 subtypes"/>
 <result pre="most common subtype, followed by ataxia-telangiectasia (AT), and ataxia oculomotor" exact="apraxia" post="type 1 (AOA1) and type 2 (AOA2) [7]. The"/>
 <result pre="6p22.3 Gait ataxia, pyramidal, extrapyramidal and bulbar signs, dysarthria, nystagmus," exact="chorea" post="and peripheral neuropathy Cognitive impairment and respiratory failure Atrophy"/>
 <result pre="ataxia, pyramidal, extrapyramidal and bulbar signs, dysarthria, nystagmus, chorea and" exact="peripheral neuropathy" post="Cognitive impairment and respiratory failure Atrophy of the cerebellum,"/>
 <result pre="pyramidal, extrapyramidal and bulbar signs, dysarthria, nystagmus, chorea and peripheral" exact="neuropathy" post="Cognitive impairment and respiratory failure Atrophy of the cerebellum,"/>
 <result pre="signs, dysarthria, nystagmus, chorea and peripheral neuropathy Cognitive impairment and" exact="respiratory failure" post="Atrophy of the cerebellum, brainstem and cerebral frontal lobe"/>
 <result pre="signs, nystagmus, lid retraction, decreased saccade velocity, amyotrophy fasciculations and" exact="peripheral neuropathy" post="Mild cognitive impairment, sleep disturbances and involuntary weight loss"/>
 <result pre="nystagmus, lid retraction, decreased saccade velocity, amyotrophy fasciculations and peripheral" exact="neuropathy" post="Mild cognitive impairment, sleep disturbances and involuntary weight loss"/>
 <result pre="TBP on chromosome 6q27 Gait ataxia, pyramidal and extrapyramidal signs," exact="chorea" post="and myoclonus Cognitive impairment and psychiatric symptoms Atrophy in"/>
 <result pre="ataxia, eye movement abnormalities, dysarthria, dysphagia, lower extremities weakness and" exact="peripheral neuropathy" post="Skeletal deformities, hypertrophic cardiomyopathy, diabetes, deafness and optic atrophy"/>
 <result pre="eye movement abnormalities, dysarthria, dysphagia, lower extremities weakness and peripheral" exact="neuropathy" post="Skeletal deformities, hypertrophic cardiomyopathy, diabetes, deafness and optic atrophy"/>
 <result pre="and peripheral neuropathy Skeletal deformities, hypertrophic cardiomyopathy, diabetes, deafness and" exact="optic atrophy" post="Atrophy of cerebellum and cervical spinal cord Decreased NAA/Cr"/>
 <result pre="11q22.3 Gait ataxia, extrapyramidal signs, oculomotor apraxia, hypotonia, areflexia and" exact="peripheral neuropathy" post="Oculocutaneous telangiectasia, immunodeficiency, cancer susceptibility, sterility, extreme radio sensitivity,"/>
 <result pre="Gait ataxia, extrapyramidal signs, oculomotor apraxia, hypotonia, areflexia and peripheral" exact="neuropathy" post="Oculocutaneous telangiectasia, immunodeficiency, cancer susceptibility, sterility, extreme radio sensitivity,"/>
 <result pre="oculomotor apraxia, hypotonia, areflexia and peripheral neuropathy Oculocutaneous telangiectasia, immunodeficiency," exact="cancer" post="susceptibility, sterility, extreme radio sensitivity, diabetes and pulmonary diseases"/>
 <result pre="Gait ataxia, extrapyramidal signs, oculomotor apraxia, areflexia, dysarthria, choreoathetosis, oculomotor" exact="apraxia" post="and peripheral neuropathy Cognitive impairment and skeletal deformities Atrophy"/>
 <result pre="extrapyramidal signs, oculomotor apraxia, areflexia, dysarthria, choreoathetosis, oculomotor apraxia and" exact="peripheral neuropathy" post="Cognitive impairment and skeletal deformities Atrophy of cerebellum N/A"/>
 <result pre="signs, oculomotor apraxia, areflexia, dysarthria, choreoathetosis, oculomotor apraxia and peripheral" exact="neuropathy" post="Cognitive impairment and skeletal deformities Atrophy of cerebellum N/A"/>
 <result pre="signs, oculomotor apraxia, chorea, upper motor neuron signs, head tremor," exact="strabismus" post="and peripheral neuropathy Mild cognitive impairment Atrophy of cerebellum"/>
 <result pre="apraxia, chorea, upper motor neuron signs, head tremor, strabismus and" exact="peripheral neuropathy" post="Mild cognitive impairment Atrophy of cerebellum Decreased glutamate, NAA"/>
 <result pre="chorea, upper motor neuron signs, head tremor, strabismus and peripheral" exact="neuropathy" post="Mild cognitive impairment Atrophy of cerebellum Decreased glutamate, NAA"/>
 <result pre="X chromosome Gait ataxia, intention tremor, eye movement abnormalities and" exact="peripheral neuropathy" post="Cognitive impairment, psychiatric symptoms, hearing loss and dysautonomia Atrophy"/>
 <result pre="chromosome Gait ataxia, intention tremor, eye movement abnormalities and peripheral" exact="neuropathy" post="Cognitive impairment, psychiatric symptoms, hearing loss and dysautonomia Atrophy"/>
 <result pre="oculomotor apraxia, AT ataxia-telangiectasia, Cho choline compounds, Cr creatine, EA" exact="episodic ataxia," post="FRDA Friedreichâ€™s ataxia, FXTAS fragile X tremor-ataxia syndrome, GABA"/>
 <result pre="NAA N-acetylaspartate, NAAG N-acetylaspartatylglutamate, PCr phosphocreatine, SOD superoxide distmutase, SCA" exact="spinocerebellar ataxia," post="tCr total creatine (Crâ€‰+â€‰PCr), tNAA total NAA (NAAâ€‰+â€‰NAAG) Generally,"/>
 <result pre="to improve gait variability in patients with various subtypes of" exact="cerebellar ataxia" post="including SCA [40]. N-acetyl-L-leucine is currently being tested in"/>
 <result pre="treatment of important diseases such as malaria, vascular diseases and" exact="cancer" post="which is deemed necessary to improve the quality of"/>
 <result pre="Fibroblast Prevented antioxidant depletion, prevented cell death N/A [66] SCA" exact="spinocerebellar ataxia," post="HEK-293 human embryonic kidney 293 cells, UPS ubiquitinâ€&quot;proteasome system,"/>
 <result pre="used to treat human embryonic kidney 293 cells (HEK-293) and" exact="neuroblastoma" post="SH-SY5Y cells expressing mutant ataxin-3 proteins. Pre-treatment with 0.1Â"/>
 <result pre="(BAX) protein and promoted the expression of anti-apoptotic marker B-cell" exact="lymphoma" post="2 (BCL2) protein. Caspase-3 activity was also reduced, which"/>
 <result pre="remedies have been shown to activate UPS, resulting in the" exact="suppression" post="of polyQ aggregation and motor dysfunction associated with SCA"/>
 <result pre="of A2A receptor is required for UPS activation [57]. The" exact="suppression" post="of polyQ aggregation was reported to prevent polyQ-induced cell"/>
 <result pre="polyQ aggregation was reported to prevent polyQ-induced cell death via" exact="suppression" post="of BCL-2-associated X (BAX), and caspase-3 and -9 activities,"/>
 <result pre="X (BAX), and caspase-3 and -9 activities, while enhancing B-cell" exact="lymphoma" post="2 (BCL) expression [55â€&quot;57]. Fig.Â 3 Schematic diagram of"/>
 <result pre="PKA protein kinase, PolyQ polyglutamine, BAX BCL-2-associated X, BCL B-cell" exact="lymphoma" post="Activation of antioxidant pathways Oxidative damage occurs when reactive"/>
 <result pre="was reduced through promotion of the glutathione/oxidised glutathione (GSH/GSSG) ratio," exact="suppression" post="of ROS levels and polyQ aggregation [59]. Pohl et"/>
 <result pre="GCLC and NQO1, as detected by Western blot analysis. Furthermore," exact="suppression" post="of polyQ aggregation was observed in cells, as shown"/>
 <result pre="and heat shock protein 70 (HSP70) chaperone in cells. Additionally," exact="suppression" post="of polyQ aggregation was observed in the cells, as"/>
 <result pre="Episodic ataxia FRDA Friedreichâ€™s ataxia AT Ataxia-telangiectasia AOA Ataxia oculomotor" exact="apraxia" post="FXTAS Fragile X tremor-ataxia syndrome TCM Traditional Chinese medicine"/>
 <result pre="LDH Lactate dehydrogenase BAX BCL-2-associated X protein BCL2 B cell" exact="lymphoma" post="2 T1-11 N6-(4-Hydroxybenzyl) adenosine JMF1907 N6-(3-Indolylethyl) adenosine GSH Glutathione"/>
 <result pre="VB, Jardim LB, Portela LV. Peripheral oxidative stress biomarkers in" exact="spinocerebellar ataxia" post="type 3/Machadoâ€&quot;Joseph disease. Front Neurol. 2017;8:485.Â 10.3389/fneur.2017.00485. 17.YangZShiCZhouLLiYYangJLiuYMaoCLuoHXuGXuYMetabolic profiling"/>
 <result pre="10.3389/fneur.2017.00485. 17.YangZShiCZhouLLiYYangJLiuYMaoCLuoHXuGXuYMetabolic profiling reveals biochemical pathways and potential biomarkers of" exact="spinocerebellar ataxia" post="3Front Mol Neurosci20191215910.3389/fnmol.2019.0015931316347 18.AdanyeguhIMHenryP-GNguyenTMRinaldiDJauffretCValabregueREmirUEDeelchandDKBriceAEberlyLEÃ–zGDurrAMochelFIn vivo neurometabolic profiling in patients"/>
 <result pre="3Front Mol Neurosci20191215910.3389/fnmol.2019.0015931316347 18.AdanyeguhIMHenryP-GNguyenTMRinaldiDJauffretCValabregueREmirUEDeelchandDKBriceAEberlyLEÃ–zGDurrAMochelFIn vivo neurometabolic profiling in patients with" exact="spinocerebellar ataxia" post="types 1, 2, 3, and 7Mov Disord201530566267010.1002/mds.2618125773989 19.Torres-RamosYMontoya-EstradaACisnerosBTercero-PÃ©rezKLeÃ³n-ReyesGLeyva-GarcÃ­aNHernÃ¡ndez-HernÃ¡ndezOMagaÃ±aJJOxidative stress"/>
 <result pre="types 1, 2, 3, and 7Mov Disord201530566267010.1002/mds.2618125773989 19.Torres-RamosYMontoya-EstradaACisnerosBTercero-PÃ©rezKLeÃ³n-ReyesGLeyva-GarcÃ­aNHernÃ¡ndez-HernÃ¡ndezOMagaÃ±aJJOxidative stress in" exact="spinocerebellar ataxia" post="type 7 is associated with disease severityCerebellum201817560160910.1007/s12311-018-0947-029876803 20.BrockmannKReimoldMGlobasCHauserTKWalterUMachullaH-JRolfsASchÃ¶lsLPET and"/>
 <result pre="with disease severityCerebellum201817560160910.1007/s12311-018-0947-029876803 20.BrockmannKReimoldMGlobasCHauserTKWalterUMachullaH-JRolfsASchÃ¶lsLPET and MRI reveal early evidence of" exact="neurodegeneration" post="in spinocerebellar ataxia type 17J Nucl Med20125371074108010.2967/jnumed.111.10154322653791 21.MundwilerAShakkottaiVGAutosomal-dominant cerebellar"/>
 <result pre="severityCerebellum201817560160910.1007/s12311-018-0947-029876803 20.BrockmannKReimoldMGlobasCHauserTKWalterUMachullaH-JRolfsASchÃ¶lsLPET and MRI reveal early evidence of neurodegeneration in" exact="spinocerebellar ataxia" post="type 17J Nucl Med20125371074108010.2967/jnumed.111.10154322653791 21.MundwilerAShakkottaiVGAutosomal-dominant cerebellar ataxiasHandb Clin Neurol201814717318510.1016/B978-0-444-63233-3.00012-929325610"/>
 <result pre="mutations of P/Q type Ca2+ channel subunit Cav2. 1 causing" exact="episodic ataxia" post="2J Med Genet.2004416e8210.1136/jmg.2003.01539615173248 26.SpaceySAdamMPArdingerHHPagonRAWallaceSEEpisodic ataxia type 2GeneReviewsÂ® [Internet]2015SeattleUniversity of"/>
 <result pre="a reviewOrphanet J Rare Dis20161115910.1186/s13023-016-0543-727884168 32.AnheimMMongaBFleuryMCharlesPBarbotCSalihMDelaunoyJPFritschMArningLSynofzikMSchÃ¶lsLSequeirosJGoizetCMarelliCLe BerIKohtJGazullaJDe BleeckerJMukhtarMDrouotNAli-PachaLBenhassineTChbichebMMâ€™ZahemAHamriAChabrolBPougetJMurphyRWatanabeMCoutinhoPTazirMDurrABriceATranchantCKoenigMAtaxia with oculomotor" exact="apraxia" post="type 2: clinical, biological and genotype/phenotype correlation study of"/>
 <result pre="study of a cohort of 90 patientsBrain2009132102688269810.1093/brain/awp21119696032 33.CoutinhoPBarbotCAdamMPArdingerHHPagonRAWallaceSEAtaxia with oculomotor" exact="apraxia" post="type 1GeneReviewsÂ® [Internet]2015SeattleUniversity of Washington 34.MoreiraM-CKoenigMAdamMPArdingerHHPagonRAWallaceSEAtaxia with oculomotor apraxia"/>
 <result pre="oculomotor apraxia type 1GeneReviewsÂ® [Internet]2015SeattleUniversity of Washington 34.MoreiraM-CKoenigMAdamMPArdingerHHPagonRAWallaceSEAtaxia with oculomotor" exact="apraxia" post="type 2GeneReviewsÂ® [Internet]2018SeattleUniversity of Washington 35.LeeheyMAFragile X-associated tremor/ataxia syndrome:"/>
 <result pre="ubiquitin proteasome pathway with traditional Chinese medicine for treatment of" exact="spinocerebellar ataxia" post="type 3Am J Chin Med.2019471639510.1142/s0192415x1950004630612452 56.ChenI-CChangK-HChenY-JChenY-CLee-ChenG-JChenC-MPueraria lobata and daidzein"/>
 <result pre="oxidative stress to reduce polyQ aggregation in cell models of" exact="spinocerebellar ataxia" post="3Neuropharmacology20148116617510.1016/j.neuropharm.2014.01.03224486383 59.ChenC-MWengY-TChenW-LLinT-HChaoC-YLinC-HChenI-CLeeL-CLinH-YWuY-RChenY-CChangK-HTangH-YChengM-LLee-ChenG-JLinJ-YAqueous extract of Glycyrrhiza inflata inhibits aggregation by"/>
 <result pre="by upregulating PPARGC1A and NFE2L2â€&quot;ARE pathways in cell models of" exact="spinocerebellar ataxia" post="3Free Radic Biol Med20147133935010.1016/j.freeradbiomed.2014.03.02324675225 60.ChangK-HChenW-LLeeL-CLinC-HKungP-JLinT-HWuY-CWuY-RChenY-CLeeG-JChenC-MAqueous extract of Paeonia lactiflora"/>
 <result pre="paeoniflorin as aggregation reducers targeting chaperones in cell models of" exact="spinocerebellar ataxia" post="3Evid Based Complement Alternat Med2013201347165910.1155/2013/47165923533486 61.PohlFTeixeira-CastroACostaMDLindsayVFiÃºza-FernandesJGouaMBermanoGRussellWMacielPKong Thoo LinPKong Thoo"/>
 <result pre="Complement Alternat Med2013201347165910.1155/2013/47165923533486 61.PohlFTeixeira-CastroACostaMDLindsayVFiÃºza-FernandesJGouaMBermanoGRussellWMacielPKong Thoo LinPKong Thoo Lin P. GST-4-dependent" exact="suppression" post="of neurodegeneration in C. elegans models of Parkinsonâ€™s and"/>
 <result pre="Med2013201347165910.1155/2013/47165923533486 61.PohlFTeixeira-CastroACostaMDLindsayVFiÃºza-FernandesJGouaMBermanoGRussellWMacielPKong Thoo LinPKong Thoo Lin P. GST-4-dependent suppression of" exact="neurodegeneration" post="in C. elegans models of Parkinsonâ€™s and Machado-Joseph disease"/>
 <result pre="extract, EGb 761, inhibits excitotoxicity in an animal model of" exact="spinocerebellar ataxia" post="type 17Drug Des Devel Ther20161072373110.2147/DDDT.S9815626937174 63.OkabeTFujisawaMSekiyaTIchikawaYGotoJSuccessful treatment of spinocerebellar"/>
 <result pre="spinocerebellar ataxia type 17Drug Des Devel Ther20161072373110.2147/DDDT.S9815626937174 63.OkabeTFujisawaMSekiyaTIchikawaYGotoJSuccessful treatment of" exact="spinocerebellar ataxia" post="6 with medicinal herbsGeriatr Gerontol Int20077219519710.1111/j.1447-0594.2007.00378.x 64.OkabeTRemission induction of"/>
 <result pre="ataxia 6 with medicinal herbsGeriatr Gerontol Int20077219519710.1111/j.1447-0594.2007.00378.x 64.OkabeTRemission induction of" exact="spinocerebellar ataxia" post="6 with medicinal herbsJ Aging Neuro Psychol.201810.29011/janp-108.100008 65.ChenC-MChenW-LHungC-TLinT-HLeeM-CChenI-CLinC-HChaoC-YWuY-RChangK-HHsieh-LiH-MLee-ChenG-JShaoyao Gancao"/>
 <result pre="a formulated Chinese medicine, reduces aggregation and exerts neuroprotection in" exact="spinocerebellar ataxia" post="type 17 (SCA17) cell and mouse modelsAging2019113986100710.18632/aging.10180430760647 66.LewS-YYowY-YLimL-WWongK-HAntioxidant-mediated protective"/>
 <result pre="Bull201033455656010.1248/bpb.33.55620410585 94.ArrudaAPHotamisligilGSCalcium homeostasis and organelle function in the pathogenesis of" exact="obesity" post="and diabetesCell Metab201522338139710.1016/j.cmet.2015.06.01026190652 95.TangT-STuHChanEYWMaximovAWangZWellingtonCLHaydenMRBezprozvannyIHuntingtin and huntingtin-associated protein 1 influence"/>
 <result pre="Biol Chem200528041349083491610.1074/jbc.M50628820016051598 108.FujikakeNNagaiYPopielHAOkamotoYYamaguchiMTodaTHeat shock transcription factor 1-activating compounds suppress polyglutamine-induced" exact="neurodegeneration" post="through induction of multiple molecular chaperonesJ Biol Chem200828338261882619710.1074/jbc.M71052120018632670 109.KuoYRenSLaoUEdgarBAWangTSuppression"/>
</results>
